Cardiovascular Disease affects around 7.5 million people in the UK (British Heart Foundation) and is estimated to be the cause of 1 in 4 premature deaths. That’s why research into new treatments for Cardiovascular Disease can be particularly important.
Atherosclerotic Cardiovascular Disease (ASCVD) is a condition caused by the buildup of plaque in the arteries. The buildup of plaque can be the potential cause of major cardiovascular events such as heart attacks and strokes.
This study is investigating the effectiveness of a treatment in reducing the risk of patients with ASCVD, or who are at high risk of an event due to health reasons, experiencing a major cardiovascular event.
This study is open to anyone aged 18 or over who:
- Has a history of ASCVD within the past 12 months
Or
Those males aged 50 or over and females aged 55 or over who:
- Have significant atherosclerotic artery disease
- Or have high-risk Type 1 or Type 2 Diabetes Mellitus
Other inclusion / exclusion criteria will apply and this will be discussed with you by one of our research team over the phone.
Your participation in this study will last for up to 4.5 years and will involve taking the study treatment, or a placebo, throughout the study. This study is placebo controlled meaning half of the participants will receive the study treatment and half will receive a placebo.
Your participation will also involve regular visits to our clinic throughout the course of the study.
You will receive reimbursement for your study related time and activities, such as visits to our clinic.
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
.jpg)
